Literature DB >> 34494149

Near-infrared fluorescence imaging-guided lymphatic mapping in thoracic esophageal cancer surgery.

Xiaojin Wang1,2, Yi Hu3,4,5, Xiangwen Wu1, Mingzhu Liang2, Zhenhua Hu6, Xiangfeng Gan1, Dan Li7, Qingdong Cao8, Hong Shan9,10.   

Abstract

PURPOSE: Identifying the lymphatic drainage pathway is important for accurate lymph node (LN) dissection in esophageal cancer (EC). This study aimed to assess lymphatic drainage mapping in thoracic EC using near-infrared fluorescent (NIRF) imaging with indocyanine green (ICG) and identify its feasibility for intraoperative LN drainage visualization and dissection.
METHODS: From November 2019 to August 2020, esophagectomy was performed using intraoperative NIRF navigation with ICG injected into the esophageal submucosa by endoscopy. All LNs were divided into four groups according to the NIRF status and presence of metastasis: NIRF+LN+, NIRF+LN-, NIRF-LN+, and NIRF-LN-.
RESULTS: Regional LNs were detected in all 84 enrolled patients with thoracic EC. A total of 2164 LNs were removed, and the mean number of dissected LNs was 25.68 ± 12.00. NIRF+ LNs were observed in all patients and distributed at 19 LN stations, which formed lymphatic drainage maps. The top five LN stations of NIRF+ probability in upper thoracic EC were No. 7, 106ecR, 107, 1, and 106recL; in middle thoracic EC, they were No. 107, 7, 110, 1, and 105; and in lower thoracic EC, they were No. 107, 7, 110, 106recR, and 1. There were no cases of ICG-related adverse events or chylothorax. The 30-day mortality rate was 0%. Major complications included anastomotic fistula (7.14%), pneumonia (4.76%), pleural effusion (13.10%), atelectasis (3.75%), hoarseness (8.33%), and arrhythmia (4.76%).
CONCLUSION: Regional LN mapping of thoracic EC was performed using ICG/NIRF imaging, which showed different preferred LN drainage stations in various anatomical locations of the thoracic esophagus. ICG/NIRF imaging is feasible for intraoperative LN drainage visualization and dissection. CLINICAL TRIAL REGISTRATION: The clinical trial registration number is NCT04173676 ( http://www. CLINICALTRIALS: gov/ ).
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Esophageal cancer; Indocyanine green; Intraoperative navigation; Lymphatic mapping; Near-infrared fluorescence imaging

Mesh:

Substances:

Year:  2021        PMID: 34494149     DOI: 10.1007/s00464-021-08720-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  31 in total

1.  Predicting lymph node metastasis for endoscopic resection of superficial esophageal squamous cell carcinoma.

Authors:  Dae Won Ma; Da Hyun Jung; Jie-Hyun Kim; Jae Jun Park; Young Hoon Youn; Hyojin Park
Journal:  J Thorac Cardiovasc Surg       Date:  2018-07-29       Impact factor: 5.209

2.  Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.

Authors:  Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Shuji Takiguchi; Kiyokazu Nakajima; Yoshiyuki Fujiwara; Koji Konishi; Masaki Mori; Yuichiro Doki
Journal:  Ann Surg Oncol       Date:  2011-05-03       Impact factor: 5.344

Review 3.  Oesophageal cancer.

Authors:  Jesper Lagergren; Elizabeth Smyth; David Cunningham; Pernilla Lagergren
Journal:  Lancet       Date:  2017-06-22       Impact factor: 79.321

4.  Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.

Authors:  Kotaro Yamashita; Masayuki Watanabe; Shinji Mine; Takanori Kurogochi; Akihiko Okamura; Masaru Hayami; Yu Imamura
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

5.  The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.

Authors:  Christophe Mariette; Guillaume Piessen; Nicolas Briez; Jean Pierre Triboulet
Journal:  Ann Surg       Date:  2008-02       Impact factor: 12.969

6.  The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study.

Authors:  Yasunori Akutsu; Ken Kato; Hiroyasu Igaki; Yoshinori Ito; Isao Nozaki; Hiroyuki Daiko; Masahiko Yano; Harushi Udagawa; Satoru Nakagawa; Masakazu Takagi; Junki Mizusawa; Yuko Kitagawa
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

7.  NIR-II/NIR-I Fluorescence Molecular Tomography of Heterogeneous Mice Based on Gaussian Weighted Neighborhood Fused Lasso Method.

Authors:  Meishan Cai; Zeyu Zhang; Xiaojing Shi; Zhenhua Hu; Jie Tian
Journal:  IEEE Trans Med Imaging       Date:  2020-01-17       Impact factor: 10.048

Review 8.  Surgical treatment for esophageal cancer. Current issues.

Authors:  Hiroyuki Kato; Minoru Fukuchi; Tatsuya Miyazaki; Masanobu Nakajima; Naritaka Tanaka; Takanori Inose; Hitoshi Kimura; Ahmad Faried; Kana Saito; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Ryokuhei Manda; Hitoshi Ojima; Katsuhiko Tsukada; Hiroyuki Kuwano
Journal:  Dig Surg       Date:  2007-04-19       Impact factor: 2.588

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

10.  Optimum lymphadenectomy for esophageal cancer.

Authors:  Nabil P Rizk; Hemant Ishwaran; Thomas W Rice; Long-Qi Chen; Paul H Schipper; Kenneth A Kesler; Simon Law; Toni E M R Lerut; Carolyn E Reed; Jarmo A Salo; Walter J Scott; Wayne L Hofstetter; Thomas J Watson; Mark S Allen; Valerie W Rusch; Eugene H Blackstone
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

View more
  3 in total

Review 1.  Intraoperative fluorescence molecular imaging accelerates the coming of precision surgery in China.

Authors:  Zeyu Zhang; Kunshan He; Chongwei Chi; Zhenhua Hu; Jie Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-01       Impact factor: 10.057

Review 2.  Fluorescent Tracers for In Vivo Imaging of Lymphatic Targets.

Authors:  P S Russell; R Velivolu; V E Maldonado Zimbrón; J Hong; I Kavianinia; A J R Hickey; J A Windsor; A R J Phillips
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 3.  Application of Indocyanine Green Enhanced Fluorescence in Esophageal Surgery: A Mini Review.

Authors:  Nicola Tamburini; Matteo Chiozza; Pio Maniscalco; Giuseppe Resta; Serafino Marino; Francesco Quarantotto; Gabriele Anania; Giorgio Cavallesco
Journal:  Front Surg       Date:  2022-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.